Yüklüyor......
Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies
Recurrent and unpredictable episodes of vaso-occlusion are the hallmark of sickle cell disease. Symptomatic management and prevention of these events using the fetal hemoglobin–reactivating agent hydroxyurea are currently the mainstay of treatment. Discoveries over the past 2 decades have highlighte...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Hematology
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3854110/ https://ncbi.nlm.nih.gov/pubmed/24052549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-05-498311 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|